Background {#Sec1}
==========

Melioidosis and leishmaniasis are two important emerging infectious diseases in Sri Lanka \[[@CR1]--[@CR3]\]. Both these diseases are prevalent in the North Central Province.

Melioidosis, caused by *Burkholderia pseudomallei*, is thought to be transmitted via inoculation of contaminated soil and less commonly via aerosol inhalation, leading to a systemic infection which may be complicated by septicemia and/or disseminated abscess formation \[[@CR4]\].

Leishmaniasis, caused by the *Leishmania* parasite occurs in the forms of cutaneous, muco-cutaneous, disseminated cutaneous and systemic infection. It is transmitted by the sand-fly \[[@CR5]\].

An extensive literature search revealed only one case report on co-infection with melioidosis and cutaneous leishmaniasis \[[@CR6]\].

Here we report a case of co-infection of melioidosis and cutaneous leishmaniasis in a patient residing at Padaviya in the North Central Province of Sri Lanka where both diseases are prevalent.

Case presentation {#Sec2}
=================

A 61 year old female with a history of diabetes and hypertension, from Padaviya, Sri Lanka, presented to the Colombo North Teaching Hospital with a history of fever with chills and rigors of one month's duration. She had developed an abscess over her left upper arm which ruptured into a non-healing ulcer coinciding with the onset of the fever.

On examination she was febrile and had an ulcer (Fig. [1](#Fig1){ref-type="fig"}) over her left upper arm which appeared unhealthy. Abdominal examination showed a smooth hepatomegaly 3 cm below the costal margin and a splenomegaly of 18 cm. Her respiratory, cardiovascular and neurological examinations were normal.Fig. 1Ulcer over the left arm of the patient

Investigations revealed a neutrophilic leukocytosis with elevated inflammatory markers (C - reactive protein -- 149 mg/L; erythrocyte sedimentation rate -- 122 mm in first hour). The blood picture was in favor of an acute bacterial infection with neutrophils with toxic changes. Serum electrolytes, serum creatinine, and liver function tests were all normal. Her first two blood cultures did not grow any organisms but the third was positive for *B. pseudomallei* cultured in MacConkey (Fig. [2](#Fig2){ref-type="fig"}) and blood agar (Fig. [3](#Fig3){ref-type="fig"}) separately*.* The patient's serum was positive for melioidosis antibodies by the indirect haemagglutination (IHA) test at a dilution of \>1/10240 which was highly significant. The ultrasound scan and the contrast enhanced computerized tomography scan of the abdomen showed hepatosplenomegaly and mild pancreatitis but the serum amylase level was normal. There was no evidence of intra-abdominal abscesses. Fasting blood sugar level was 110 mg/dl and the capillary blood sugar levels during the hospital stay were well controlled with metformin 1 g 12 hourly and gliclazide 40 mg 12 hourly.Fig. 2*B. pseudomallei* cultured in MacConkey agar Fig. 3*B. pseudomallei* cultured in blood agar

Since the ulcer remained non-healing, two slit skin smears were done, both of which showed *Leishmania* amastigotes (Fig. [4](#Fig4){ref-type="fig"}). However, serum antibodies against the Lc-rK39 antigen (using Kalazar Detect™ kit produced by Inbios International Inc.) of the organism was negative, excluding systemic infection. Wound swab for bacterial culture showed no growth.Fig. 4Slit skin smear of the patient showing *Leishmania* amastigotes

The patient was initially commenced on intravenous ceftazidime 2 g six hourly but did not respond even after five days. She developed multiple abscesses all over the body (Fig. [5](#Fig5){ref-type="fig"}) one week into the hospital admission. However, pus cultures were negative for *B. pseudomallei.* She was then switched to a three week course of intravenous meropenem 1 g 8 hourly to which the fever responded. She was transferred to the Anuradhapura Teaching Hospital for continuation of meropenem for a further week and was subsequently discharged on eradication therapy with oral co-trimoxazole 960 mg (160 mg trimethoprim and 800 mg sulfamethoxazole) 12 hourly for six months and referred to the clinic for follow up.Fig. 5Abscess over the abdomen. Multiple abscesses such as these were present in the patient

The skin lesion was cauterized and no further treatment was administered since it was a local infection with the *Leishmania* parasite. The ulcer had healed almost completely by the time of discharge.

At 3 months' follow up she remains afebrile, the ulcer healed completely and the hepatosplenomegaly absent.

Discussion and conclusions {#Sec3}
==========================

The pathogenesis of the two illnesses has been evaluated at molecular level and certain similarities have been found. It has been shown that increased TNF-α levels predispose to both diseases \[[@CR7]\] and both illnesses are acted upon by a Type 1 T cell response which targets intracellular pathogens \[[@CR8]\].

The ulcer on the arm of the patient probably occurred after a bite by the sand-fly which inoculated the leishmania organism in it. Secondary contamination of the ulcer with *B.pseudomallei* due to the high environmental prevalence of the organism could have caused the melioidosis infection. Diabetes mellitus would have predisposed the patient to acquiring the infection as well \[[@CR9]\].

The presence of hepatosplenomegaly in the patient initially provoked the possibility of 'kala azar' or visceral leishmaniasis but since the patient was not very ill, was antibody negative and since she recovered with antibiotics to melioidosis, this assumption was discarded later \[[@CR10], [@CR11]\].

The diagnosis of melioidosis is often elusive but can be made through antibody assays and direct isolation via cultures \[[@CR12]\]. The positive antibody titer and culture in this patient, together, pins the diagnosis of melioidosis.

Melioidosis treatment has two arms, the intensive phase and eradication phase. During the intensive phase, ceftazidime, meropenem or imipenem is used for a duration of 2--4 weeks. Co-trimoxazole may be added if the patient is poorly responding. The eradication phase uses co-trimoxazole or doxycycline up to a period of six months \[[@CR13]\].

Cutaneous leishmaniasis can be treated with local cauterization or intra-lesional administration of sodium stibogluconate \[[@CR14]\].

Since there was only one case report of a co-infection with both these illnesses and because there are set guidelines for the management of them individually, we treated the two infections separately.

As both melioidosis and leishmaniasis are emerging infectious diseases in Sri Lanka, physicians should have a high clinical suspicion when dealing with patients with pyrexia of unknown origin, especially when they're from areas where the diseases are more prevalent.

IHA

:   Indirect haemagglutination

TNF-α

:   Tumor necrosis factor alpha
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